The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...

EUROPEAN shares started the week on a positive note on Monday after the United States and China agreed to temporarily slash ...

Health-care companies rose sharply after President Trump signed an executive order designed to lower what Americans pay for prescription drugs that offered pharmaceutical companies room for ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

As a Biden administration ban on so-called “junk fees” took effect Monday, Ticketmaster said it would start displaying the ...

Key Takeaways Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as ...

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...